ChemicalBook >?? ???? >N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
|
|
N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine ??
- ???
- 75-77 °C
- ??
- 1.205±0.06 g/cm3(Predicted)
- ?? ?? (pKa)
- 13.36±0.50(Predicted)
??
N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine C??? ??, ??, ??
N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine ?? ?? ? ???
???
?? ??
N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine ?? ??
???( 19)?? ??
| ??? | ?? | ??? | ?? | ?? ? | ?? |
|---|---|---|---|---|---|
| Standardpharm Co. Ltd. | 86-714-3992388 |
overseasales1@yongstandards.com | United States | 14332 | 58 |
| China National Standard Pharmaceutical Corporation Limited | +8615391658522 |
overseasales@yongstandards.com | China | 11922 | 58 |
| Hubei Yangxin Medical Technology Co., Ltd. | 15374522761 |
3003392093@qq.com | China | 9342 | 55 |
| Chengdu Novel Biomedical Co., Ltd. | 028-85255396 18302801538 |
cdnovell@163.com | China | 2381 | 58 |
| Shenzhen Polymeri Biochemical Technology Co., Ltd. | +86-400-002-6226 +86-13028896684; |
sales@rrkchem.com | China | 57422 | 58 |
| Guangzhou Dreampharm Biotechnology Co., Ltd. | 020-36607679 17825480238 |
3008233746@qq.com | China | 9936 | 12 |
| Jinan blalong chemical co. LTD | 2710913286@.com |
1513643261@qq.com | China | 14246 | 58 |
| Shandong WorldSun Biological Technology Co., Ltd. | 0531-88723173 18596073690 |
1047208234@qq.com | China | 6049 | 58 |
| Hubei Xinyang Medical Technology Co., Ltd | 15347293736 |
2853117764@qq.com | China | 9916 | 58 |
| Molcoo Chemicals Inc. | 18576690171 |
3001025734@qq.com | China | 9128 | 58 |
N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine ?? ??:
4-(Hydroxyamino)-4-oxobutanoic acid
CYANOACETIC ACID-OSU
N-Hydroxysuccinimide
Tofacitinib Impurity 2
Ethyl S-4-chloro-3-hydroxybutyrate
2-amino-4-fluoro-5-nitrobenzoic acid
TF-A
(3R,4R)-N,4-dimethyl-piperidin-3-amine
(3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile
(S)-N4-(3-chloro-4-fluorophenyl)-7-(tetrahydrofuran-3-yloxy)quinazoline-4,6-diaMine
Tofacitinib Impurity 20
R-afatinib
6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine
3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide
3-((3S,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
Tofacitinib Impurity 19
3-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyriMidin-4-yl)(Methyl)aMino)-4-Methylpiperidin-1-yl)-3-oxopropanenitrile
(3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine